Clinical Trial Update: A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

The trial update notes termination of the Phase I/II study of AEZS-108 in urothelial carcinoma patients who failed platinum-based chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• AEZS-108 (zoptarelin doxorubicin)

Snippet

Sponsor: AEterna Zentaris | Conditions: Urothelial Carcinoma | Phase 1, Phase 2 | Status: TERMINATED